Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Randomized Clinical Trial BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization

NCT04424134 is registered in ClinicalTrials.gov with Lomonosov Moscow State University Medical Research and Educational Center as lead sponsor.

NCT NCT04424134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04424134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Randomized Clinical Trial BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization
Lead sponsor
Lomonosov Moscow State University Medical Research and Educational Center
Phase
Phase 3
Overall status
Unknown status
Start date
May 16, 2020
Completion date
August 23, 2020
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19